Clinical outcome of breast cancer occurring after treatment for Hodgkin's lymphoma: case-control analysis

Radiat Oncol. 2009 Jun 30:4:19. doi: 10.1186/1748-717X-4-19.

Abstract

Background: To evaluate diagnosis, management and outcome of breast cancer (BC) occurring after irradiation for Hodgkin's lymphoma (HL).

Methods: 39 cases of BC in 28 HL survivors were retrospectively reviewed. 21 patients were included in a case-control analysis.

Results: The median age at diagnosis of HL and BC was 25.3 and 45.3 years, respectively. The median interval to develop BC was 16.1 years. Eleven women (39.2%) had bilateral disease. Mode of detection of the index breast cancers was by mammographic screening in 17 patients (60.7%), palpable lump in 8 patients (28.6%), clinical examination in two patients (7.1%), and unknown in one patient (3.6%). Case-control analysis showed that histological features and prognosis of BC after HL were similar to those of primary BC, however, for BC after HL, mastectomy was the predominant surgery (P = .001) and adjuvant radiotherapy and anthracycline-based chemotherapy were less frequently used as compared to primary BC (P < .001 and .003, respectively).

Conclusion: The previous history of HL does not appear to be a poor prognostic factor for BC occurring thereafter.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms / etiology*
  • Case-Control Studies
  • Child
  • Combined Modality Therapy
  • Female
  • Hodgkin Disease / drug therapy
  • Hodgkin Disease / radiotherapy*
  • Humans
  • Middle Aged
  • Neoplasm Staging
  • Neoplasms, Radiation-Induced / etiology*
  • Neoplasms, Second Primary / etiology*
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Survival Rate
  • Treatment Outcome
  • Young Adult